Lu, Xiaoyin http://orcid.org/0000-0002-9244-325X
Lofgren, Shane M.
Zhao, Yuehui
Mazur, Pawel K. http://orcid.org/0000-0002-5820-8344
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA236118, R01CA278940, R01CA272843, R01CA236949)
Cancer Prevention and Research Institute of Texas (RP220391, RR160078, RP210028)
U.S. Department of Defense (CA181486)
Article History
Received: 12 September 2022
Accepted: 1 August 2023
First Online: 31 August 2023
Competing interests
: X.L., S.M.L. and P.K.M. have filed a patent application related to SSN-seq. P.K.M. is a scientific consultant and stockholder of Amplified Medicines, Ikena Oncology and Alternative Bio. The other authors declare no competing interests.